BreachRx, provider of the first intelligent incident response platform designed for the entire enterprise, today announced the closing of an oversubscribed $15 million Series A funding round led by Ballistic Ventures, with participation from SYN Ventures, Overline, and Silver Buckshot Ventures. The company also announced the appointments of Ballistic Ventures General Partner and former Mandiant CEO Kevin Mandia to the Board of Directors, and best-selling author and former New York Times lead cybersecurity reporter Nicole Perlroth as Board Observer. The investment brings the company’s total funding raised to over $23 million. The BreachRx platform is a secure, central workspace for every stakeholder across an organization to coordinate and streamline cybersecurity incident response management. It enables real-time, cross-functional collaboration by clearly defining roles, responsibilities, and timelines, ensuring every team member knows exactly what to do and when to do it. The platform reduces costs and increases efficiency by automating the creation of tailored playbooks for any type of incident and reports to track and measure response outcomes for Boards, auditors, and regulators. “The most forward-thinking CISOs understand that cyberattacks and breaches are events that companies must manage with effective command and control,” said Kevin Mandia. “Every company should consider how to prepare for and manage through a cyber incident – and BreachRx empowers companies to both plan and execute through cyber events in a manner that promotes far more effectiveness and resilience.”

Full report : BreachRx Closes $15M Series A Funding to End the Chaos of Cybersecurity Incident Response.

For more see the OODA Company Profile on BreachRx.